USANA Health Sciences (NYSE:USNA) Given New $38.00 Price Target at DA Davidson

USANA Health Sciences (NYSE:USNA) had its price target cut by DA Davidson from $46.00 to $38.00 in a report published on Thursday, Benzinga reports. They currently have a neutral rating on the stock. DA Davidson also issued estimates for USANA Health Sciences’ Q3 2024 earnings at $0.46 EPS.

Separately, StockNews.com lowered shares of USANA Health Sciences from a strong-buy rating to a buy rating in a research note on Wednesday.

USANA Health Sciences Trading Up 1.9 %

USANA Health Sciences stock opened at $42.62 on Thursday. The company has a fifty day simple moving average of $46.01 and a 200-day simple moving average of $46.97. The stock has a market cap of $811.91 million, a P/E ratio of 13.28, a price-to-earnings-growth ratio of 1.41 and a beta of 0.90. USANA Health Sciences has a 12-month low of $40.51 and a 12-month high of $68.00.

USANA Health Sciences (NYSE:USNA) last announced its quarterly earnings results on Tuesday, July 23rd. The company reported $0.54 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.65 by ($0.11). USANA Health Sciences had a return on equity of 11.13% and a net margin of 6.29%. The business had revenue of $212.87 million for the quarter, compared to analysts’ expectations of $218.64 million. During the same period last year, the firm earned $0.89 earnings per share. As a group, sell-side analysts forecast that USANA Health Sciences will post 2.48 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other news, CFO G Doug Iiekking sold 5,198 shares of the business’s stock in a transaction dated Tuesday, May 7th. The stock was sold at an average price of $44.76, for a total value of $232,662.48. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. In other news, CFO G Doug Iiekking sold 5,198 shares of USANA Health Sciences stock in a transaction on Tuesday, May 7th. The shares were sold at an average price of $44.76, for a total value of $232,662.48. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, insider Daniel A. Macuga sold 3,791 shares of the stock in a transaction on Thursday, May 2nd. The stock was sold at an average price of $47.14, for a total transaction of $178,707.74. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 31,591 shares of company stock valued at $1,458,098. 0.33% of the stock is currently owned by insiders.

Institutional Trading of USANA Health Sciences

Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Dimensional Fund Advisors LP grew its stake in shares of USANA Health Sciences by 3.3% in the 4th quarter. Dimensional Fund Advisors LP now owns 677,664 shares of the company’s stock valued at $36,323,000 after purchasing an additional 21,524 shares during the last quarter. Vanguard Group Inc. grew its position in USANA Health Sciences by 2.5% in the 3rd quarter. Vanguard Group Inc. now owns 1,567,182 shares of the company’s stock valued at $91,853,000 after buying an additional 38,533 shares during the last quarter. CWM LLC increased its stake in USANA Health Sciences by 49.6% in the 4th quarter. CWM LLC now owns 1,267 shares of the company’s stock valued at $68,000 after buying an additional 420 shares during the period. Strs Ohio raised its position in USANA Health Sciences by 9.2% during the 4th quarter. Strs Ohio now owns 11,900 shares of the company’s stock worth $637,000 after buying an additional 1,000 shares during the last quarter. Finally, Allianz Asset Management GmbH lifted its stake in shares of USANA Health Sciences by 43.0% in the 4th quarter. Allianz Asset Management GmbH now owns 26,970 shares of the company’s stock worth $1,446,000 after acquiring an additional 8,108 shares during the period. 54.25% of the stock is owned by hedge funds and other institutional investors.

USANA Health Sciences Company Profile

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.